MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

CXCR7 modulator 2

CAS No. : 2227426-37-9

產(chǎn)品活性：CXCR7 modulator 2 is a modulator of C-X-C Chemokine Receptor Type 7 (CXCR7), with a K_i of 13 nM.

研究領(lǐng)域：GPCR/G Protein  |  Immunology/Inflammation

作用靶點(diǎn)：CXCR

In Vitro: CXCR7 modulator 2 (compound 18) demonstrates potent CXCR7-binding affinity (K_i=13 nM) and β-arrestin activity (EC₅₀=11 nM). CXCR7 modulator 2 also exhibits improved selectivity in the GPCR panel and an improved therapeutic index in the hERG patch-clamp assay in comparison with 11c. CXCR7 modulator 2 exhibits moderate to high in vitro turn over in both NADPH-supplemented mouse-liver microsomes (MLM, 93 μL/min/mg) and hepatocytes (28 μL/min per million cells), shows poor passive absorptive permeability in the MDCK II-permeability assay, and has good aqueous solubility. CXCR7 modulator 2 is rapidly absorbed with a mean maximal plasma concentration (C_max) of 682 ng/mL, which occurrs at 0.25 h (T_max). The corresponding mean area under the plasma-concentration-versus-time profile (AUC) is 740 ng/mL/h.

In Vivo: The administration of isoproterenol for 9 days leads to the development of cardiac fibrosis, as attested by the approximately 4-fold increase in collagen deposition relative to that in the control, which is detected by picrosirius-red staining. Treatment with CXCR7 modulator 2 results in a statistically significant reduction in cardiac fibrosis, thereby demonstrating the protective role of CXCR7 modulation with CXCR7 modulator 2 in an isoproterenol-induced cardiac injury.

相關(guān)產(chǎn)品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Endocrinology Compound Library  |  Targeted Diversity Library  |  Chemokine Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Nicotinamide N-oxide  |  SX-517  |  AMG 487 (S-enantiomer)  |  TC14012  |  CTCE-9908  |  CXCR2 antagonist 3  |  Kynurenic acid-d₅  |  (R,R)-CXCR2-IN-2  |  IT1t dihydrochloride  |  NUCC-390  |  Ac-Pro-Gly-Pro-OH  |  Vimnerixin  |  NBI-74330  |  CXCR4 antagonist 9  |  Quetmolimab  |  PS372424 hydrochloride  |  SCH 546738  |  vMIP-II (1-21)  |  CXCR2-IN-1  |  Mavorixafor  |  Reparixin L-lysine salt  |  VUF11207 fumarate  |  NoxaBH3  |  Kynurenic acid  |  CXCR4 antagonist 2  |  Balixafortide  |  Plerixafor octahydrochloride  |  Ladarixin

熱門產(chǎn)品線：重組蛋白  |  化合物庫  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點(diǎn)擊化學(xué)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,，我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物,；
•   50,000 多種高選擇性抑制劑,、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)；
•   產(chǎn)品種類涵蓋各種重組蛋白,，多肽,，常用試劑盒 ，更有 PROTAC,、ADC 等特色產(chǎn)品,，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目,；
•   提供虛擬篩選,，離子通道篩選，代謝組學(xué)分析檢測分析,，藥物篩選等專業(yè)技術(shù)服務(wù),；
•   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系,；
•   提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項(xiàng)質(zhì)檢報(bào)告,，確保產(chǎn)品的高純度、高品質(zhì),；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證,；
•   Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,，為您提供*新的活性化合物,；
•   與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作。